Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1730 to 1779 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1730\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phospholipid scramblase 4 (pl scramblase 4) (ca(2+)-dependent phospholipid scramblase 4). [source:swissprot;acc:q9nrq2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6259.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6684.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06781\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1731\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lamin b2. [source:swissprot;acc:q03252]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5840.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6236.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06776\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1732\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proteasome subunit beta type 7 precursor (ec 3.4.25.1) (proteasome subunit z) (macropain chain z) (multicatalytic endopeptidase complex chain z). [source:swissprot;acc:q99436]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5781.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6173.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06768\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent elongation factor 1-alpha 1 (ef-1-alpha-1) (elongation factor 1 a-1) (eef1a-1) (elongation factor tu) (ef-tu). [source:swissprot;acc:p04720]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5874.83\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6272.26\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06765\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc-finger protein zpr1 (zinc finger protein 259). [source:swissprot;acc:o75312]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent elongation factor 1-alpha 2 (ef-1-alpha-2) (elongation factor 1 a-2) (eef1a-2) (statin s1). [source:swissprot;acc:q05639]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent twinkle; likely ortholog of mouse t7 gp4-like protein with intramitochondrial nucleoid localization. [source:refseq;acc:nm\_021830]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5925.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6326.43\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06763\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rabaptin, rab gtpase binding effector protein 1; rabaptin-5; neurocrescin. [source:refseq;acc:nm\_004703]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ischemia/reperfusion inducible protein. [source:refseq;acc:nm\_024640]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5885.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6282.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06761\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent argininosuccinate synthase (ec 6.3.4.5) (citrulline--aspartate ligase). [source:swissprot;acc:p00966]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5695.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6079.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06743\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine-protein kinase plk (ec 2.7.1.-) (plk-1) (serine- threonine protein kinase 13) (stpk13). [source:swissprot;acc:p53350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5878.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6274.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06738\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine-protein kinase dcamkl1 (ec 2.7.1.-) (doublecortin- like and cam kinase-like 1). [source:swissprot;acc:o15075]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6297.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6721.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06734\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent microtubule-associated protein, rp/eb family, member 2; t-cell activation protein, eb1 family; apc-binding protein eb1. [source:refseq;acc:nm\_014268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6298.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6722.61\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06729\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1743\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histidine-rich membrane protein ke4. [source:swissprot;acc:q92504]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6298.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6722.65\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent microtubule-associated protein rp/eb family member 1 (apc-binding protein eb1). [source:swissprot;acc:q15691]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent microtubule-associated protein rp/eb family member 3 (protein eb3). [source:swissprot;acc:q9upy8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6298.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6722.62\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent regucalcin gene promotor region related protein; rgpr-p117. [source:refseq;acc:nm\_033127]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5683.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6065.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06728\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cerebral cell adhesion molecule. [source:refseq;acc:nm\_016174]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 9596.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10241.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06724\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent doublecortin (lissencephalin-x) (lis-x) (doublin). [source:swissprot;acc:o43602]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6301.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6724.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06723\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent electron transfer flavoprotein alpha-subunit, mitochondrial precursor (alpha-etf). [source:swissprot;acc:p13804]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7919.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8452.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06721\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1750\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent arp2/3 complex 34 kda subunit (p34-arc) (actin-related protein 2/3 complex subunit 2). [source:swissprot;acc:o15144]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5384.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5746.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06715\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60 kda tat interactive protein (tip60) (hiv-1 tat interactive protein) (cpla(2) interacting protein). [source:swissprot;acc:q92993]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6011.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6414.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06711\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent copper-transporting atpase 1 (ec 3.6.3.4) (copper pump 1) (menkes disease-associated protein). [source:swissprot;acc:q04656]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5941.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6339.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0671\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 2 subunit 2 (eukaryotic translation initiation factor 2 beta subunit) (eif-2-beta). [source:swissprot;acc:p20042]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5423.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5787.46\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06707\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent copper-transporting atpase 2 (ec 3.6.3.4) (copper pump 2) (wilson disease-associated protein). [source:swissprot;acc:p35670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5941.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6340.32\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent chromodomain y-like protein 2. [source:refseq;acc:nm\_152342]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7101.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7577.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06703\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s29. [source:swissprot;acc:p30054]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3582.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3357.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.067\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent testis-specific chromodomain y protein 1. [source:swissprot;acc:q9y6f8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 7101.15\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7576.84\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06699\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent chromodomain protein, y chromosome-like isoform a; cdy-like, autosomal; testis-specific chromodomain y-like protein. [source:refseq;acc:nm\_004824]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent testis-specific chromodomain protein y protein 2. [source:swissprot;acc:q9y6f7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7101.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7576.87\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent thioredoxin interacting protein; upregulated by 1,25-dihydroxyvitamin d-3. [source:refseq;acc:nm\_006472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5693.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6075.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06698\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent electron transfer flavoprotein beta-subunit (beta-etf). [source:swissprot;acc:p38117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7794.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8316.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06692\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tumor susceptibility gene 101 protein. [source:swissprot;acc:q99816]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6122.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6531.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06672\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dystrobrevin alpha (dystrobrevin-alpha). [source:swissprot;acc:q9y4j8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5829.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6218.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06668\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1764\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent beta-1-syntrophin (59 kda dystrophin-associated protein a1, basic component 1) (dapa1b) (tax interaction protein 43) (tip-43) (syntrophin 2) (bsyn2). [source:swissprot;acc:q13884]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5829.61\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6218.27\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06667\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1765\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent beta-2-syntrophin (59 kda dystrophin-associated protein a1, basic component 2) (syntrophin 3) (snt3) (syntrophin-like) (sntl). [source:swissprot;acc:q13425]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nitrilase 1. [source:refseq;acc:nm\_005600]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent utrophin (dystrophin-related protein 1) (drp1) (drp). [source:swissprot;acc:p46939]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1768\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial precursor (ec 2.3.1.-) (e2) (dihydrolipoamide branched chain transacylase) (bckad e2 subunit). [source:swissprot;acc:p11182]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dystrophin. [source:swissprot;acc:p11532]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1770\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent angiomotin. [source:refseq;acc:nm\_133265]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1771\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent angiomotin like 2; leman coiled-coil protein; angiomotin-like protein 2. [source:refseq;acc:nm\_016201]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha-1-syntrophin (59 kda dystrophin-associated protein a1, acidic component 1) (pro-tgf-alpha cytoplasmic domain-interacting protein 1) (tacip1) (syntrophin 1). [source:swissprot;acc:q13424]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1773\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dystrobrevin beta (beta-dystrobrevin) (dtn-b). [source:swissprot;acc:o60941]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5829.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6218.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.06666\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj470l14.3 (novel protein similar to the arp2/3 protein complex subunit p21-arc (arc21)). [source:sptrembl;acc:q9h5b6]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5386.37\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5744.89\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.06656\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1775\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 258. [source:refseq;acc:nm\_145310]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1776\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 261 (dxs6673e protein). [source:swissprot;acc:q14202]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 262; cell death inhibiting rna. [source:refseq;acc:nm\_005095]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent actin-like protein 2 (actin-related protein 2). [source:swissprot;acc:o15142]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent conserved oligomeric golgi complex component 3 (vesicle docking protein sec34 homolog) (p94). [source:swissprot;acc:q96jb2]\vspace{3pt}}&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/